Cargando…

Clinical utility of brain-derived neurotrophic factor as a biomarker with left ventricular echocardiographic indices for potential diagnosis of coronary artery disease

Brain-derived neurotrophic factor (BDNF) plays a central pivotal role in the development of the cardiovascular system. Recent evidence suggests that BDNF has adverse subclinical cardiac remodeling in participants with cardiovascular disease risk factors. Relating serum BDNF levels with two-dimension...

Descripción completa

Detalles Bibliográficos
Autores principales: Monisha, K. G., Prabu, Paramasivam, Chokkalingam, M., Murugesan, Ram, Milenkovic, Dragan, Ahmed, Shiek S. S. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530751/
https://www.ncbi.nlm.nih.gov/pubmed/33004884
http://dx.doi.org/10.1038/s41598-020-73296-6
_version_ 1783589631951896576
author Monisha, K. G.
Prabu, Paramasivam
Chokkalingam, M.
Murugesan, Ram
Milenkovic, Dragan
Ahmed, Shiek S. S. J.
author_facet Monisha, K. G.
Prabu, Paramasivam
Chokkalingam, M.
Murugesan, Ram
Milenkovic, Dragan
Ahmed, Shiek S. S. J.
author_sort Monisha, K. G.
collection PubMed
description Brain-derived neurotrophic factor (BDNF) plays a central pivotal role in the development of the cardiovascular system. Recent evidence suggests that BDNF has adverse subclinical cardiac remodeling in participants with cardiovascular disease risk factors. Relating serum BDNF levels with two-dimensional echocardiographic indices will provide insights into the BDNF mediated pathophysiology in coronary artery disease (CAD) that may shed light upon potential diagnostic biomarkers. For the study, 221 participants were recruited and classified based on coronary angiogram examination as control (n = 105) and CAD (n = 116). All participants underwent routine blood investigation, two-dimensional echocardiography, and serum BDNF estimation. As a result, total cholesterol, triglyceride, low-density lipid, high-density lipid, HbA1c (glycosylated hemoglobin), serum creatinine, eosinophils, lymphocyte, monocytes, neutrophils, and platelets were significantly elevated in CAD individuals compared to controls. Notably, the serum BDNF was significantly lower in individuals with CAD (30.69 ± 5.45 ng/ml) than controls (46.58 ± 7.95 ng/ml). Multivariate regression analysis showed neutrophils, total cholesterol, left ventricular mass index, mitral inflow E/A ratio, and pulmonary vein AR duration were associated with low BDNF in CAD. Four independent support vector machine (SVM) models performed to ensure the BDNF level in the classification of CAD from healthy controls. Particularly, the model with serum BDNF concentration and blood parameters of CAD achieved significant improvement from 90.95 to 98.19% in detecting CAD from healthy controls. Overall, our analysis provides a significant molecular linkage between the serum BDNF level and cardiovascular function. Our results contribute to the emerging evidence of BDNF as a potential diagnostic value in CAD that might lead to clinical application.
format Online
Article
Text
id pubmed-7530751
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75307512020-10-02 Clinical utility of brain-derived neurotrophic factor as a biomarker with left ventricular echocardiographic indices for potential diagnosis of coronary artery disease Monisha, K. G. Prabu, Paramasivam Chokkalingam, M. Murugesan, Ram Milenkovic, Dragan Ahmed, Shiek S. S. J. Sci Rep Article Brain-derived neurotrophic factor (BDNF) plays a central pivotal role in the development of the cardiovascular system. Recent evidence suggests that BDNF has adverse subclinical cardiac remodeling in participants with cardiovascular disease risk factors. Relating serum BDNF levels with two-dimensional echocardiographic indices will provide insights into the BDNF mediated pathophysiology in coronary artery disease (CAD) that may shed light upon potential diagnostic biomarkers. For the study, 221 participants were recruited and classified based on coronary angiogram examination as control (n = 105) and CAD (n = 116). All participants underwent routine blood investigation, two-dimensional echocardiography, and serum BDNF estimation. As a result, total cholesterol, triglyceride, low-density lipid, high-density lipid, HbA1c (glycosylated hemoglobin), serum creatinine, eosinophils, lymphocyte, monocytes, neutrophils, and platelets were significantly elevated in CAD individuals compared to controls. Notably, the serum BDNF was significantly lower in individuals with CAD (30.69 ± 5.45 ng/ml) than controls (46.58 ± 7.95 ng/ml). Multivariate regression analysis showed neutrophils, total cholesterol, left ventricular mass index, mitral inflow E/A ratio, and pulmonary vein AR duration were associated with low BDNF in CAD. Four independent support vector machine (SVM) models performed to ensure the BDNF level in the classification of CAD from healthy controls. Particularly, the model with serum BDNF concentration and blood parameters of CAD achieved significant improvement from 90.95 to 98.19% in detecting CAD from healthy controls. Overall, our analysis provides a significant molecular linkage between the serum BDNF level and cardiovascular function. Our results contribute to the emerging evidence of BDNF as a potential diagnostic value in CAD that might lead to clinical application. Nature Publishing Group UK 2020-10-01 /pmc/articles/PMC7530751/ /pubmed/33004884 http://dx.doi.org/10.1038/s41598-020-73296-6 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Monisha, K. G.
Prabu, Paramasivam
Chokkalingam, M.
Murugesan, Ram
Milenkovic, Dragan
Ahmed, Shiek S. S. J.
Clinical utility of brain-derived neurotrophic factor as a biomarker with left ventricular echocardiographic indices for potential diagnosis of coronary artery disease
title Clinical utility of brain-derived neurotrophic factor as a biomarker with left ventricular echocardiographic indices for potential diagnosis of coronary artery disease
title_full Clinical utility of brain-derived neurotrophic factor as a biomarker with left ventricular echocardiographic indices for potential diagnosis of coronary artery disease
title_fullStr Clinical utility of brain-derived neurotrophic factor as a biomarker with left ventricular echocardiographic indices for potential diagnosis of coronary artery disease
title_full_unstemmed Clinical utility of brain-derived neurotrophic factor as a biomarker with left ventricular echocardiographic indices for potential diagnosis of coronary artery disease
title_short Clinical utility of brain-derived neurotrophic factor as a biomarker with left ventricular echocardiographic indices for potential diagnosis of coronary artery disease
title_sort clinical utility of brain-derived neurotrophic factor as a biomarker with left ventricular echocardiographic indices for potential diagnosis of coronary artery disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530751/
https://www.ncbi.nlm.nih.gov/pubmed/33004884
http://dx.doi.org/10.1038/s41598-020-73296-6
work_keys_str_mv AT monishakg clinicalutilityofbrainderivedneurotrophicfactorasabiomarkerwithleftventricularechocardiographicindicesforpotentialdiagnosisofcoronaryarterydisease
AT prabuparamasivam clinicalutilityofbrainderivedneurotrophicfactorasabiomarkerwithleftventricularechocardiographicindicesforpotentialdiagnosisofcoronaryarterydisease
AT chokkalingamm clinicalutilityofbrainderivedneurotrophicfactorasabiomarkerwithleftventricularechocardiographicindicesforpotentialdiagnosisofcoronaryarterydisease
AT murugesanram clinicalutilityofbrainderivedneurotrophicfactorasabiomarkerwithleftventricularechocardiographicindicesforpotentialdiagnosisofcoronaryarterydisease
AT milenkovicdragan clinicalutilityofbrainderivedneurotrophicfactorasabiomarkerwithleftventricularechocardiographicindicesforpotentialdiagnosisofcoronaryarterydisease
AT ahmedshiekssj clinicalutilityofbrainderivedneurotrophicfactorasabiomarkerwithleftventricularechocardiographicindicesforpotentialdiagnosisofcoronaryarterydisease